CROss Alliance® is a Swiss CRO specialised in early clinical development. With more than 500 trials performed at CROSS phase I unit or in selected EU sites, we are experts in PK, bioequivalence, first in man, tolerability studies including cardiac safety and efficacy models in healthy volunteers.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    1997
  • Number of employees in Switzerland
    20-49
Key business